PODD Conference: Partnership Opportunities in Drug Delivery

When your therapy demands more from your device, we deliver

From high-concentration formulations to lyophilisation and intraocular delivery: who will solve your toughest drug delivery device challenges?

With nearly four decades of applied science and engineering leadership, we excel in tackling highly technical issues - from mechanics, electronics, and fluidics to stability, connectivity, user experience and manufacturability - to help pharma and biotech innovators build devices that bring therapies to market faster and deliver exceptional patient outcomes.

Meet us at PODD 2026 to discuss your next breakthrough.

Sign up for TTP's PODD Talks

Beyond Conventional Injection: Lessons from Microneedle Drug Delivery - Track 2B - Novel Injectable & Non-Injectable Technologies

‍
Matthew Parker, Device Innovation Lead, TTP

The continued rise of GLP-1 and other metabolic therapies is driving renewed interest in alternatives to conventional subcutaneous delivery, from ingestible devices to nasal technologies.

But these approaches bring additional challenges for development and commercialisation: the interplay of drug, device and tissue; new usability risks; and the need to scale novel manufacturing processes in parallel with clinical development.

Drawing on TTP's experience developing microneedle delivery systems, we share a risk-based approach to navigating these challenges. By first understanding the fundamental parameters and sensitivities governing delivery, we explore how delivery and scalability risks can be tackled independently, and progressively integrated through clinical development to avoid compounding risk.

We conclude by considering how this framework can be applied across other alternative delivery approaches, despite very different delivery physics and biological interfaces.

Find out more or add this talk to your calendar here.

How Much Device Do You Need? - Track 4A & 4B Cell, Gene and Novel Biologics Delivery

‍
Steve Gowers, Head of Pharma , TTP

Developing Local Drug Delivery Systems from Preclinical Studies to Commercial Product

For advanced modalities, like gene therapies, you often need a device to deliver the therapy before the delivery physics, formulation, procedure and user needs are well understood.

When this happens, how do drug development teams build confidence in their therapy without compounding risk, cost and development time?

Drawing on our experience in ophthalmic delivery, this talk shares TTP’s experience in developing phase-appropriate drug delivery tools, experiments and evidence that allow the device to mature alongside the drug development.

Find out more or add this talk to your calendar here.

How TTP can help

• Strategic innovation: Tackling advanced delivery challenges, from complex formulations and lyophilisation to next-generation delivery systems and beyond.
• End-to-end development: Expertise across early feasibility, rapid prototyping, design verification, and manufacturing transfer.
• Cross-disciplinary expertise: A dedicated team of drug delivery scientists, engineers, and designers developing advanced devices together.
• Patient-centric design: Enabling safe, intuitive use - from intraocular therapies to large-volume injections at home.
• Innovation at speed: Applying rigorous technical insight to accelerate timelines without compromising quality.
• Partner mindset: Flexible, collaborative engagement models designed to fit your device development programme and business needs.

Find out more about our work

Ground-up device development - Learn how we deliver novel devices that meet commercial and patient needs.

Targeted delivery - ocular innovation - Find out about our pioneering work in the ocular field.

Delivery for novel therapies and formulations - Discover how we're solving the complexities of formulation, containment and delivery in next-gen therapies.

Design for scalability - Gain insights into how we're creating predictability in an uncertain process.

We’ll be at PODD 2026 – will you?

Meet us at PODD 2026 to explore how we can help you tackle the toughest challenges in drug delivery. Whether you’re advancing a new therapy, scaling production, or exploring connected health, our team is ready to partner with you.

To book a meeting, use the ‘book a meeting’ form below or visit us at booth 705.